신게스톨

Cingestol
신게스톨
Cingestol.svg
임상자료
상명루티산
기타 이름19-Nor-17α-pregn-5-en-20-yn-17β-ol; O.V. 28[1][2]
경로:
행정
구강
식별자
  • (8R,9S,10R,13S,14S,17R)-17-17-ethyl-13-메틸-2,3,4,7,8,9,10,11,12,14,15,16-도데하이드로-1H 사이클로펜타[a]17-ol
CAS 번호
펍켐 CID
켐스파이더
유니
CompTox 대시보드 (EPA)
ECHA InfoCard100.037.225 Edit this at Wikidata
화학 및 물리적 데이터
공식C20H28O
어금질량284.443 g·2013−1
3D 모델(JSmol)
  • C[C@]12CC[C@H]3[C@@H](CC=C4CCC[C@H]34)[C@H]1CC[C@@]2(O)C#C
  • InChI=1S/C20H28O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h1,8,15-18,21H,4-7,9-13H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1
  • 키:HSYWFJBHXIUCZ-XGXHKTLJSA-N

17α-ethylestr-5-en-17β-ol로도 알려진 Cingestol(INN, USAN) (구 잠정 브랜드명 류티산)[3][4]은 시판되지 않은 19-nortestosterone 그룹의[5][6] 스테로이드 프로게스틴이다.[7] 1969년에[7] 합성되어 1970년대에 오르가논에 의해 저선량 프로게스테겐 전용 피임약으로 개발되었으나,[8][9][10][11] 1984년에는 여전히 "조사중"[12]으로 기술되었다. 그 약은 Lynestrenol이성질체로서 C5와 C6의 이중결합이다.[1]

참고 항목

참조

  1. ^ a b M. Tausk (1975). Pharmacology of hormones. Thieme. p. 126,129. ISBN 978-3-13-518901-7.
  2. ^ Concours médical. 1976. p. 1083.
  3. ^ Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. 1987. p. 2995.
  4. ^ Janet Brotherton (1976). Sex hormone pharmacology. Academic Press. p. 12. ISBN 978-0-12-137250-7.
  5. ^ Andrejus Korolkovas (16 August 1988). Essentials of Medicinal Chemistry. Wiley. ISBN 978-0-471-88356-2.
  6. ^ WHO Technical Report Series. World Health Organization. 1981. p. 75. ISBN 9789241206570.
  7. ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 279–. ISBN 978-1-4757-2085-3.
  8. ^ Amnuay Tapingkae (1974). Directory of selected scholars and researchers in Southeast Asia. Regional Institute of Higher Education and Development. p. 687.
  9. ^ Michael H. Briggs; Maxine Briggs (1976). Biochemical contraception: prospects for human development. Academic Press. p. 283. ISBN 978-0-12-134640-9.
  10. ^ Aref I, Hefnawi F, Kandil O, Aziz MT (1973). "Effect of minipills on physiologic responses of human cervical mucus, endometrium, and ovary". Fertil. Steril. 24 (8): 578–83. doi:10.1016/s0015-0282(16)39850-8. PMID 4124151.
  11. ^ Kićović PM, Kovacević S, Djokic LJ, Milojević S, Janoskov J, Behlilović B, Jeremić N (1974). "Clinical evaluation of a new low dose progestagen-only contraceptive containing cingestol". Int. J. Fertil. 19 (3): 171–5. PMID 4375129.
  12. ^ Windsor Cooper Cutting; T. Z. Csáky; Byron A. Barnes (1984). Cutting's Handbook of Pharmacology: The Actions and Uses of Drugs. Appleton-Century-Crofts. p. 439. ISBN 978-0-8385-1418-4.